Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
February 2012 Vol 5, No 1, Special Issue
First Cost Analysis of Long-Term Management of CML
Neil Canavan
,
Neil Canavan
Read More
Graft-versus-Host Disease Often Leads to Posttransplant Readmission, High Costs
Read More
Is Plerixafor Cost-Effective for Stem-Cell Mobilization?
Caroline Helwick
,
Caroline Helwick
Read More
Leukemia
Bosutinib Shows Superior Results in CML
Neil Canavan
,
Neil Canavan
Read More
Leukemia
Novel Oral B-Cell Receptor Inhibitor Very Effective in Chronic Lymphocytic Leukemia
Caroline Helwick
,
Caroline Helwick
,
Caroline Helwick
Read More
Multiple Myeloma
,
Multiple Myeloma
VISTA Final Analysis Upholds Survival Benefit of Bortezomib at 5 Years
Caroline Helwick
,
Caroline Helwick
Read More
Multiple Myeloma
,
Multiple Myeloma
Maintenance Strategies in Elderly Patients with Myeloma Not Eligible for Transplant
Caroline Helwick
,
Caroline Helwick
Read More
Guidelines for Molecular/Cytogenetic Tests Can Eliminate Overordering, Reduce Costs
Caroline Helwick
,
Caroline Helwick
Read More
Conference Highlights ASH
Ready-Made Platelets? A Boon for Patients If It Works
Neil Canavan
,
Neil Canavan
Read More
Cost of Treating Myeloproliferative Neoplasms Is Significant
Neil Canavan
,
Neil Canavan
Read More
1
2
3
Page 1 of 3
Results 1 - 10 of 29